Brief: Zelira Therapeutics Seeks Trading Halt
29/05/2023 24:07
May 29 (Reuters) - Zelira Therapeutics Ltd ZLD.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON RESULTS OF ITS
IRB-APPROVED MULTI-ARM HEAD-TO-HEAD STUDY
Source text for Eikon: ID:nASX96zpdq
Further company coverage: ZLD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zelira Therapeutics
See all newsBrief: Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV
Australia's Zelira Therapeutics surges on $33 million funding for drug trial
Australia's Zelira Therapeutics climbs to over 7-month high on securing patents
Brief: Zelira Therapeutics Receives USD$1.4 Million Unsecured Loan Funds From Chairman
Brief: Zelira Therapeutics Ltd Says Zld Secures Us$1.4M Unsecured Chairman Loan Facility